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Received 24 Apr 2017; first review completed 25 May 2017; accepted in final form 25 May 2017ABSTRACT—Introduction: The study investigated the effect of untreated cardiac arrest (CA), that is, ‘‘no-flow’’ time, on
postresuscitation myocardial and neurological injury, and survival in a pig model to identify an optimal duration that
adequately reflects the most frequent clinical scenario.Methods: An established model of myocardial infarction followed by
CA and cardiopulmonary resuscitation was used. Twenty-two pigs were subjected to three no-flow durations: short
(8–10min), intermediate (12–13min), and long (14–15min). Left ventricular ejection fraction (LVEF) was assessed
together with thermodilution cardiac output (CO) and high sensitivity cardiac troponin T (hs-cTnT). Neurological impairment
was evaluated by neurological scores, serum neuron specific enolase (NSE), and histopathology. Results: More than 60%
of animals survived when the duration of CA was 13min, compared to only 20% for a duration 14min. Neuronal
degeneration and neurological scores showed a trend toward a worse recovery for longer no-flow durations. No animals
achieved a good neurological recovery for a no-flow 14min, in comparison to a 56% for a duration 13min (P¼0.043).
Serum NSE levels significantly correlated with the no-flow duration (r¼0.892). Longer durations of CA were characterized
by lower LVEF and CO compared to shorter durations (P<0.05). The longer was the no-flow time, the higher was the
number of defibrillations delivered (P¼0.043). The defibrillations delivered significantly correlated with LVEFand plasma hs-
cTnT. Conclusions: Longer no-flow durations caused greater postresuscitation myocardial and neurological dysfunction
and reduced survival. An untreated CA of 12–13min may be an optimal choice for a clinically relevant model.
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Cardiac arrest (CA) is burdened by high mortality and severe
neurological impairment among survivors (1). Up to 64% of
out-of-hospital (OH) CA victims die on the scene or on the way
to the hospital during ambulance transport (2). Moreover, more
than half of the successfully resuscitated patients die within
72 h after hospital admission, such that final survival is approxi-
mately 8% in Europe, with great differences among countries
(2–4). Patients who eventually survive to hospital discharge
frequently suffer from a persistent neurocognitive impairment
that deeply impacts the quality of life (1, 4, 5). Postcardiac
arrest syndrome (PCAS) is responsible for these subsequent in-
hospital mortality and poor neurological outcome (3).rint requests to Giuseppe Ristagno, MD, IRCCS-Istituto di Ricerche
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1Novel therapeutic approaches have been conceived and
tested to improve outcome of CA. Indeed, experimental models
represent the starting point for evaluating the effect of new
interventions before their implementation into clinical practice.
However, CA models are often not consistent in methods and
experimental designs, such that their findings might be hardly
reproduced in humans. An example is represented by the
duration of untreated CA, known as ‘‘no-flow’’ time, that,
although recognized as one of the main determinants of the
PCAS severity, remains highly variable in the experimental
studies (6–11). This potentially raises concerns on the
adequacy of available experimental models in reflecting the
real clinical scenario (12).
Clinical studies report an average emergency medical
service arrival time to the CA scene of 6–8 min; however,
considering the intervals for emergency call, ambulance dis-
patch, arrival to the patient, and onset of cardiopulmonary
resuscitation (CPR), it is reasonable that the no-flow duration
accounts for even longer periods. Based on that, the duration
of untreated CA in experimental models should reasonably
last more than 8 min to adequately reflect the clinical OHCA
environment (4, 13–16). Indeed, a shorter or a longer exper-
imental no-flow duration may be associated with a lesser or a
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studied interventions may overestimate or fail to show any
effect on outcome.
The main focus of the present study is to provide evidence
for designing more clinically relevant animal models, able
to resemble CA outcomes similar to those reported in
humans more recently, that is, a long-term survival with
favorable neurological recovery in approximately 50% of
resuscitated patients (4, 6). Thus, the study systematically
investigates the effect of different durations of untreated CA
on postresuscitation myocardial and neurological injury and
survival in a pig model of CPR with the aim to identify an
optimal no-flow interval to be used for interventional exper-
imental studies.AQ5PATIENTS AND METHODS
All procedures involving animals and their care were in conformity with
national and international laws and policies. Approval of the study was obtained
by the institutional review board committee and governmental institution. To
systematically investigate the effect on outcome of different durations of
untreated CA, the present study includes data from an earlier investigation
in which animals were subjected to 8 min of untreated CA (8), and data from an
immediately subsequent investigation directed to increase the duration of no-
flow up to a clinical relevant model (in term of survival and neurological
recovery), in which animals were prospectively subjected to a duration of no-
flow progressively increased from 10 to 12, 13, 14, and 15 min. Investigators
and methods of induction of CA, of CPR, and measurements were the same in
all the experiments.
Animal preparation
Twenty-two male domestic pigs (40 1 kg) were fasted the night before
experiment except for free water access. Anesthesia was induced by intra-
muscular injection of ketamine (20 mg/kg) followed by intravenous admin-
istration of propofol (2 mg/kg) and sufentanyl (0.3mg/kg) through an ear vein
access. Anesthesia was then maintained by continuous intravenous infusion of
propofol (4–8 mg/kg/h) and sufentanyl (0.3mg/kg/h). A cuffed tracheal tube
was placed, and animals were mechanically ventilated with a tidal volume of
15 mL/kg and FiO2 of 0.21. Respiratory frequency was adjusted to maintain
the end-tidal partial pressure of carbon dioxide (EtCO2) between 35 and 40
mmHg, monitored with an infrared capnometer (8). For measurement of aortic
pressure, a fluid-filled 7F catheter was advanced from the right femoral artery
into the thoracic aorta. For measurements of right atrial pressure (RAP), core
temperature, and cardiac output (CO), a 7F pentalumen thermodilution
catheter was advanced from the right femoral vein into the pulmonary artery.
Conventional pressure transducers were used (MedexTransStar, Monsey, NY).
Myocardial infarction was induced in a closed-chest preparation by intra-
luminal occlusion of the left anterior descending (LAD) coronary artery (8).
More in details, a 6F balloon-tipped catheter was inserted from the right
common carotid artery and advanced into the aorta and then into the LAD,
beyond the first diagonal branch, with the aid of image intensification and
confirmed by injection of radiographic contrast media. For inducing ventric-
ular fibrillation (VF), a 5F pacing catheter was advanced from the right jugular
vein into the right ventricle. The position of all catheters was confirmed by
characteristic pressure morphology and/or fluoroscopy. Frontal plane electro-
cardiogram was recorded. Heart rate and rhythms were monitored by electro-
cardiograms.
Experimental procedure
The balloon of the LAD coronary artery catheter was then inflated with
0.7 mL of air to occlude the flow. Occlusion was confirmed by the rapid
occurrence of progressive electrocardiographic ST segment elevation. If VF did
not occur spontaneously, after 10 min it was induced with 1–2 mA AC current
delivered to the right ventricle endocardium (8). Ventilation was discontinued
after the onset of VF. After 8–15 min of untreated VF, CPR, including chest
compressions with the LUCAS 2 (PhysioControl Inc, Lund, Sweden) and
ventilation with oxygen (tidal volume of 500 mL, 10 breaths/min), was initiated.
More specifically, six pigs had a no-flow time of 8 min (8), two of 10 min, five of
12 min, three of 13 min, one of 14 min, and five of 15 min. For homogeneouscomparison, animals were assigned to three groups of no-flow duration:
‘‘short’’ 8–10 min (n¼ 8); ‘‘intermediate’’ 12–13 min (n¼ 8); and ‘‘long’’
14–15 (n¼ 6). After 5 min of CPR, defibrillation was attempted with a single
biphasic 150-J shock, using an MRx defibrillator (Philips Medical Systems,
Andover, Mass). If resuscitation was not achieved, CPR was resumed and
continued for 1 min before a subsequent defibrillation. Adrenaline (30mg/kg)
was administered via the right atrium after 2 and 7 min of CPR. The resusci-
tation procedures were continued until resuscitation or for a maximum of
15 min. Successful resuscitation was defined as restoration of an organized
cardiac rhythm with a mean arterial pressure (MAP) of more than 60 mmHg.
After that, if VF reoccurred, it was treated by immediate defibrillation. During
CPR, the LAD occlusion balloon was deflated to avoid possible rupture during
mechanical chest compression, but the catheter was left in place to maintain a
partial occlusion of the LAD, which was approximately 75% of the internal
lumen, as previously reported (17). Immediately after resuscitation, the LAD
occlusion balloon was reinflated and the catheter correct placement was
reconfirmed by fluoroscopy. After successful resuscitation, anesthesia was
maintained, and animals were monitored during the 4-h treatment. Forty-five
minutes after resuscitation, the LAD catheter was withdrawn. Temperature of
the animals was maintained at 38 0.58C during the whole experiment. After
4 h of treatment, catheters were removed, wounds were repaired, and the
animals were extubated and returned to their cages. Analgesia with butorphanol
(0.1 mg/kg) was administered by intramuscular injection. At the end of the
postresuscitation observation period, up to 96 h, animals were reanesthetized for
echocardiographic examination and blood sample withdrawn. Animals were
then sacrificed painlessly with an intravenous injection of 150 mg/kg sodium
thiopental, and heart and brain were harvested. Autopsy was performed
routinely for potential injuries due to CPR or obfuscating disease.
Measurements
Hemodynamics, EtCO2, and electrocardiogram were recorded continuously
on a personal computer-based acquisition system (WinDaq DATAQ Instruments
Inc, Akron, Ohio). The coronary perfusion pressure was computed from the
differences in time-coincident diastolic aortic pressure and right atrial pressure.
CO was measured by thermodilution technique (COM-2; Baxter International
Inc, Deerfield, Ill). Echocardiography was performed using a phase-array
multifrequency 2.5- to 5-MHz probe (CX50, Philips, The Netherlands), and
left ventricular (LV) ejection fraction (EF) was calculated from single plane
two-dimensional echocardiography from apical four chamber view using the
modified single-plane Simpson’s rule (8). Arterial blood gases were assessed
with i-STAT System (Abbott Laboratories, Princeton, NJ). Plasma high-sen-
sitivity cardiac troponin T (hs-cTnT) and serum neuron-specific enolase (NSE)
were measured with electrochemiluminescence assays (Roche Diagnostics
Italia, Monza, Italy).
As previously described (8), neurologic recovery was assessed with the
neurologic alertness score (NAS), ranging from 100 (normal) to 0 (brain death),
and with the swine neurologic deficit score (NDS), ranging from 0 (normal) and
400 (brain death). Finally, the functional recovery was evaluated before
sacrifice according to overall performance categories (OPCs) as follows:
1¼ normal, 2¼ slight disability, 3¼ severe disability, 4¼ coma, and 5¼ brain
brain death or death. Outcome was defined poor when OPC was 3. Scores
were assessed by veterinarian doctors blinded to no-flow duration.
At sacrifice, the brains were carefully removed from the skulls and fixed in
4% buffered formalin. Standardized 5-mm coronal slices were taken. The
hippocampal CA1 sector and the cortex were chosen as regions of interest and
were paraffin embedded. More specifically, the hippocampal CA1 sector was
selected because it is well recognized to be associated with postresuscitation
cognitive dysfunction in humans and animals (3, 8, 18, 19). The cortex was
selected to evaluate the effect of prolonged no-flow durations on cortical
neurons, known to be more resistant to ischemia (18, 19); and have a
histological correspondence with the neurological performances evaluated
through the NAS and NDS scores, which are mainly related to the cortical
responses. Five-micrometer-thick sections were then obtained and stained with
hematoxylin–eosin. The proportion of neuronal loss and degeneration/necrosis
(shrunken neurons with deeply acidophilic cytoplasm and pyknotic nucleus)
was quantified as absent (0), rare (1), few (2), and numerous (3). An
experienced pathologist, blinded to treatment, performed the assessments.
For transmission electron microscopy analysis, samples from hippocampus
were reduced and fixed with 4% paraformaldehyde and 2% glutaraldehyde in
phosphate buffer 0.12 mol/L pH 7.4 overnight at 48C, followed by incubation at
room temperature for 2 h in 2% OsO4. After dehydration in a graded series of
ethanol preparations, tissue samples were cleared in propylene oxide,
embedded in epoxy medium (Epoxy Embedding Medium kit; Sigma-Aldrich)
and polymerized at 608C for 72 h. Ultra-thin (60 nm thick) sections of areas of
interest were obtained with a Leica EM UC6 ultramicrotome (Leica Micro-
systems), counterstained with uranyl acetate and lead citrate and examined with
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TABLE 1. Resuscitation outcomes, hemodynamics, and blood gas analysisAQ9
Short, 8–10min, n¼8 Intermediate, 12–13min, n¼8 Long, 14–15min, n¼6 P value ANOVA
Total defibrillations, n 3 [1; 10] 10 [2; 11] 15 [11; 26] 0.043
Duration of CPR, s 315 [300; 509] 361 [325; 455] 480 [334; 757] 0.307
Successful resuscitation, n/n (%) 8/8 (100) 8/8 (100) 5/6 (83) 0.247
Long-term survival, n/n (%) 7/8 (88) 5/8 (63) 1/5 (20)* 0.078
Heart rate, beat/min
BL 9910 938 868 0.602
PR 2 h 1276 15613 16411* 0.040
PR 4 h 1308 12912 1435 0.595
Mean arterial pressure, mmHg
BL 994 1013 965 0.702
PR 2 h 826 856 922 0.571
PR 4 h 927 762 786 0.107
Right atrial pressure, mmHg
BL 51 61 81 0.081
PR 2 h 71 81 91 0.346
PR 4 h 71 70 120*,** <0.001
End-tidal CO2, mmHg
BL 360 371 360 0.406
PR 2 h 360 360 371 0.302
PR 4 h 361 360 370 0.633
LV CO, L/min
BL 4.50.5 4.40.3 4.00.3 0.735
PR 2 h 3.30.3 3.30.3 2.80.6 0.604
PR 4 h 3.20.3 3.20.4 1.90.1 0.032
LV infarct size area, % 9.72.0 6.50.7 13.1 †
pH
BL 7.4950.017 7.5190.016 7.5130.027 0.636
PR 2 h 7.4340.026 7.3940.042 7.3950.017 0.583
PR 4 h 7.4620.017 7.4290.027 7.4100.011 0.251
PaO2, mmHg
BL 7911 835 832 0.931
PR 2 h 897 1098 8410 0.111
PR 4 h 883 10011 709 0.074
PaCO2, mmHg
BL 382 371 371 0.789
PR 2 h 401 391 411 0.615
PR 4 h 421 401 421 0.302
HCO3, mmol/L
BL 29.31.0 30.31.2 29.81.2 0.828
PR 2 h 27.20.9 24.52.0 25.40.7 0.353
PR 4 h 29.91.1 26.81.3 26.70.4 0.088
BE, mmol/L
BL 6.41.1 7.41.5 6.71.6 0.865
PR 2 h 3.11.4 0.22.6 0.51.0 0.402
PR 4 h 6.11.3 2.51.5 2.00.4 0.089
†ANOVA was not performed due to a single animal survived in the ‘‘long’’ group.
*P <0.017 vs. ‘‘short’’; **P <0.017 vs. ‘‘intermediate.’’
BE indicates base excess; BL, baseline; CO, cardiac output; CPR, cardiopulmonary resuscitation; LV, left ventricle; PaO2, arterial partial pressure of
oxygen; PaCO2, arterial partial pressure of carbon dioxide; PR, postresuscitation.
Data are expressed as meanSEM.
SHOCK MONTH 2017 NO-FLOW DURATION AND CARDIAC ARREST MODELS 3Energy Filter Transmission Electron Microscope (EFTEM, ZEISS LIBRA 120)
equipped with YAG scintillator slow scan CCD camera.
Myocardial infarct was assessed by tetrazolium chloride (TTC) staining. The
LV was sliced into 5-mm-thick transverse sections, which were incubated
(20 min) in a solution of TTC and then transferred to 4% formalin overnight
before image analysis. Infarct size was reported as percentage of TTC-negative
area relative to LV area (8).
Statistical analysis
One sample Kolmogorov–Smirnov Z test was used to confirm normal
distribution of the data. For comparisons of time-based variables, repeated
measures analysis of variance (ANOVA) was used. For comparisons between
groups at the given time points, one-way ANOVA with Tukey’s multiple
comparison was used for normally distributed variables, while Kruskal–Wallis
test with Dunn’s multiple comparison was used for not normally distributed
variables. When the dependent variable was categorical, chi-square test was
performed. Linear correlations between parametric variables were calculatedusing the Pearson correlation coefficient. Spearman test was performed for the
nonparametric variable correlation analyses. For survival analysis, Kaplan–Meier
survival curves and log-rank (Mantel-Cox) test were used. Data are expressed as
meanSEM, except for CPR duration, number of defibrillations delivered, hs-
cTnT and NSE, presented as median [Q1–Q3]. A P  0.05 was regarded as
statistically significant; for the multiple comparisons, the P value for statistical
significance was adjusted to 0.017. Data analyses were performed using
GraphPad Prism (version 6.05 for Windows; GraphPad Software, La Jolla, Calif).RESULTS
No significant differences in hemodynamic parameters, EtCO2,
cardiac function, and blood gases analysis were observed among
groups at baseline (Table 1). Duration of CPR was similar in the
three groups (P not significant) and all animals were successfully
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FIG. 1. Kaplan–Meier of postresuscitation survival after an
untreated cardiac arrest of short, intermediate, and long duration.
AQ7
4 SHOCK VOL. xx, No. x BABINI ET AL.resuscitated except for one animal in the long duration group.
More than 80% of animals in the short and 60% in the intermediate
no-flow duration survived up to 4 days, in contrast to only 20% in
the long duration group (P¼ 0.017 long vs. short; Table 1 and
Fig. 1). The longer was the duration of no-flow, the higher was the
total number of defibrillations delivered (r¼ 0.497, P¼ 0.02),
with a 5-fold difference between the long and the short duration
groups (Table 1 and Fig. 2).
Resuscitation outcome, postresuscitation hemodynamics,
and blood gas analyses data are shown in Table 1. No signifi-
cant differences in MAP were observed among the groups,
except for a trend toward a higher MAP in the short no-flow
group compared to the others (Table 1). Animals subjected to
longer durations of no-flow presented significantly higher
postresuscitation HR and RAP and a lower LV CO, compared
to those in the shorter durations (P¼ 0.040, P< 0.001, and
P¼ 0.032, respectively; Table 1).FIG. 2. (A) Total number of defibrillations before successful resuscita
duration. (B) Left ventricular ejection fraction (LV EF) at baseline (BL), and at 2 and
short, intermediate, and long duration. (C) Plasma high sensitive cardiac troponin T
cardiac arrest of short, intermediate, and long duration. (D). Serum euronal specific
group.LV EF decreased in each group after resuscitation (Fig. 2).
Postresuscitation LV EF was significantly lower in the longer
duration groups compared to the shorter one (P< 0.05). LV EF
at 4 h postresuscitation was inversely correlated with the
duration of no-flow (r¼0.65, P¼ 0.006). As expected, an
inverse relationship between LV EF and the number of deliv-
ered defibrillations was observed (r¼0.52, P¼ 0.038).
LV infarct size was comparable after short or intermediate
duration of no-flow, while it was greater in the single animal
that survived in the long duration group (Table 1). There was a
trend toward higher plasma levels of hs-cTnT in the long
duration group (Fig. 2). Hs-cTnT release significantly corre-
lated with the LV infarct size (r¼ 0.77, P¼ 0.004), but not with
the duration of no-flow (r¼ 0.225, P¼ 0.37). Nevertheless,
levels of hs-cTnT were significantly related to the number of
defibrillations received by the animals (r¼ 0.679, P¼ 0.002).
Sixty-two percent of the animals resuscitated in the short and
50% in the intermediate no-flow duration group survived with a
good neurological recovery (OPC  2), in contrast to no
animals in the long duration group, in which only one of the
five resuscitated animals survived and had an OPC of three
(P¼ 0.043, Fig. 3). NAS and NDS showed a trend toward a
worse recovery for longer durations of no-flow, with the worst
scores observed in the group with the longest duration of
untreated CA (Fig. 3). NSE release paralleled the trend
observed in the neurological recovery, with higher circulating
levels in the instance of longer durations of no-flow (P< 0.001,
Fig. 2). Indeed, the duration of untreated CA strongly correlated
with NSE release (r¼ 0.892, P< 0.001).
Neurological recovery and NSE data were confirmed by the
histological findings, showing greater neuronal degeneration/tion after an untreated cardiac arrest of short, intermediate, and long
4h postresuscitation (PR), and at sacrifice, after anuntreated cardiac arrest of
(hs-cTnT) levels at BL, and at 2 and 4h PR, and at sacrifice, after an untreated
enolase (NSE) levels at baseline and at sacrifice. *P<0.05 vs. short duration
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FIG. 3. (A) Overall performance category (OPC); (B) neuronal degeneration in the hippocampal CA1 sector and in cortex, (C) neurological
alertness score (NAS); and (D) neuronal deficit score (NDS), after an untreated cardiac arrest of short, intermediate, and long duration.
SHOCK MONTH 2017 NO-FLOW DURATION AND CARDIAC ARREST MODELS 5necrosis in hippocampus and in cortex for increasing no-flow
durations, with the single animal survived in the long duration
group showing the most severe neuronal injury with associated
gliosis and perivascular inflammation (Figs. 3 and 4). Ultra-
structural imaging showed mitochondria in neurons undergoing
degenerative processes of increasing severity, that is, disruption
of cristae and reduction of matrix density, for longer no-flow
durations; neuropil, normally composed by a tightly packedFIG. 4. Hematoxylin–eosin staining 200 magnification of hippocampa
intermediate, and long duration. Short duration: hippocampus—some degenera
and pyknotic nucleus are intermixed with numerous normal neurons; cortex—n
hippocampus—numerous degenerated/necrotic neurons with some normal neuro
degenerated/necrotic neurons. Long duration: hippocampus—almost all neuron
presence of numerous degenerated/necrotic neurons, gliosis, and perivascular inmyriad of axons, dendrites, and glial processes, also presented a
progressive vacuolization and loss of structure (Fig. 5).DISCUSSION
The present study systematically investigated, for the first
time, the effect of different no-flow intervals on PCAS severity
in an experimental model, describing a linear associationl CA1 sector and cortex after an untreated cardiac arrest (CA) of short,
ted/necrotic neurons characterized by shrinkage, deeply acidophilic cytoplasm
ormal histological appearance of the nervous tissue. Intermediate duration:
ns still detectable (on the left side of the picture); cortex—presence of some
s are degenerated/necrotic; cortex—severe damage characterized by the
flammatory cells cuffing.
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FIG. 5. Ultrastructural analysis of hippocampus.Representative images by transmission electron microscopy of neurons (mitochondria indicated by white
arrows) and neuropil (single vacuoles indicated by asterisks and agglomerated vacuoles encircled), after an untreated cardiac arrest (CA) of short, intermediate,
and long duration. Short duration: mitochondria show only irregular shapes and moderate damage of inner membranes; neuropil normally composed by a tightly
packed myriad of axons, dendrites, and glial processes presents some vacuolated and enlarged processes. Intermediate duration: mitochondria show disruption
of cristae and remarkable reduction of matrix density; neuropil shows a more evident vacuolization. Long duration: mitochondria show a complete loss of internal
components; the confluence of vacuoles determines an edematous-like massive loss of the neuropilAQ8 .
6 SHOCK VOL. xx, No. x BABINI ET AL.between the duration of untreated CA and the ensuing heart and
brain injury. Indeed, longer no-flow durations were associated
with lower percentage of survival and worse postresuscitation
myocardial dysfunction and neurological recovery compared to
shorter durations. However, the aim of the study was not to
describe worse outcomes for longer no-flow durations, but
rather to provide evidence and results that can be applied
experimentally to design more clinically relevant studies.
Showing increasing organ damage and lower survival for
longer untreated CA durations was only the pragmatic way
to deliver our message.
Duration of no-flow is one of the key features that deeply
impact on CA survival and neurological injury (15, 16, 20–22).
Designing realistic models for preclinical research, with
specific attention to the duration of untreated CA, is therefore
crucial to correctly evaluate the potential benefit of new treat-
ments. For this reason, the no-flow duration should be wisely
selected to obtain an experimental model that closely reflects
the human pathophysiology of CA and PCAS and whose
observations might be easily translated clinically (12).
CA duration is, however, extremely variable in CPR models
(7–11). In a review including 42 experimental articles, signifi-
cant differences in research methodology have been reported,
highlighting a poor clinical representativeness for numerous
studies. More specifically, the duration of untreated CA ranged
from 0 to 15 min, with the majority of the experiments employ-
ing a duration as short as 3 min or even lesser (12). In other
recent reviews on animal models of CPR, longer no-flow
intervals, close to 8 min, were reported (23, 24). Nevertheless,
our study showed that an untreated CA with a duration up to
10 min caused only a limited injury, which accounted for a
survival in almost 90% of resuscitated animals. Only when theduration of no-flow exceeded 12 min, data on survival were
similar to those reported clinically (25).
Indeed, in our model, a duration of untreated CA of
12–13 min showed the best compromise in terms of survival
and severity of myocardial and neurological injury, with out-
comes that resembled those observed in the clinical scenario,
that is, a long-term survival with favorable neurological out-
come (OPC 1–2) in 50% of resuscitated animals (4, 6). In
contrast, for longer no-flow durations, that is, 14–15 min, 0%
of animals survived with a good neurological recovery. Thus,
considering clinical survival with good functional recovery, in
our opinion an interval of 12–13 min may be an optimal choice
for the duration of untreated CA to be used in experimental
models, while with longer no-flow intervals, the mortality was
unacceptably high. Moreover, in view of using a preclinical
model to investigate new neuroprotective interventions, a CA
duration14 min determines probably a too extensive neuronal
damage with important loss of ultrastructure, such that any
potential benefit might be obfuscated.
The myocardial dysfunction observed after CA is a transient
phenomenon due to cell stunning rather than permanent injury
that usually spontaneously reverses within the following 2–3
days (3, 22, 26). In our model, the postresuscitation myocardial
dysfunction, evaluated by LV EF, was deeply depressed in all
groups of animals during the first 4 h postresuscitation, with a
greater impairment after a duration 14 min. The worse myo-
cardial dysfunction after a longer untreated CA may be
explained as the result of a more severe ischemic insult,
supported by the 2-fold greater infarct size in the single animal
that survived and by the higher plasma hs-cTnTs in this group
of animals. Another explanation may be represented by the
greater number of defibrillations delivered to the animals (27).
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SHOCK MONTH 2017 NO-FLOW DURATION AND CARDIAC ARREST MODELS 7Indeed, repetitive defibrillations are known to increase the
severity of postresuscitation myocardial dysfunction (28),
and in our study, the longer was the duration of no-flow, the
greater was the number of defibrillation attempts and such a
number of electrical countershocks was significantly related
with the systolic dysfunction, represented by the LV EF impair-
ment, and with the myocardial injury, reported as hs-
cTnT release.
We recognize several limitations in the interpretation of our
findings. First, the study was not a randomized trial, but
included data from an earlier investigation (8), using the same
model, and data from new investigations, in which animals
were prospectively subjected to progressively longer durations
of no-flow. However, the studies were performed consecutively,
and investigators, methods for induction of CA and CPR
procedures, and methodologies for measurements were the
same throughout the experiments, such to allow for reprodu-
cibility, consistency of the results, and thus strength of the final
message. Second, catheter-related thrombosis might develop
very easily during the 45 min postresuscitation LAD occlusion
because of the hypercoagulative feature of the porcine blood,
potentially leading to emboli release during the LAD catheter
withdraw. We decided not to administer heparin during the
catheter removal to avoid potential impact on reperfusion;
however, all the animals were subjected to the same procedure,
limiting the effect of unexpected emboli on differences in
outcome among groups. Third, the study did not assess the
effect of different CPR or ‘‘low-flow’’ durations, which are
known to potentially play a role in outcome (29). Fourth, the
effect of body temperature on neurological outcomes was not
evaluated, although target temperature management (TTM) is
currently a standard of care after OHCA for its beneficial
effects on survival and neuroprotection (4, 30, 31). Never-
theless, the quality of CPR was standardized and the duration of
CPR was similar in all the groups. Moreover, all the animals
received the same postresuscitation management, with the core
temperature maintained at normothermia during the 4 h of
intensive observation. Indeed, the main focus of the study
was to assess the impact of the sole no-flow duration on
outcome of CA, excluding any other potential bias, that is,
TTM or duration of CPR. Therefore, our results are robust to
show the direct impact of no-flow duration on the severity of
PCAS and outcome of CA. Finally, we acknowledge that results
from animal models of CA and CPR may be dependent on the
local conditions and skills present in different laboratories.
However, this article highlights the need for a standardization
of procedures and may pave the route for a share of methodo-
logical details and adoption of experimental designs based on
the clinical scenario.
The above limitations notwithstanding, in this porcine
model, a linear relation between the duration of untreated
CA and the severity of PCAS was observed. Indeed, longer
no-flow durations caused greater postresuscitation myocardial
and neurological dysfunction and reduced the survival rate, in
comparison to shorter durations. A duration of untreated CA of
12–13 min may be an optimal choice for clinically relevant CA
animal models because it yields survival rates and neurological
outcomes similar to those observed in the clinical scenario.ACKNOWLEDGMENTS
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